Skip to main content

Volume 20 - Issue 8 - August, 2008

11/24/2008
Jeffrey J. Popma, MD, FACC, FSCAI
The AngioJet device has been shown to be a safe and effective device for mechanical thrombectomy, yet its association with severe bradyarrhythmia has impeded its broad acceptance and widespread use. This “brady effect” has forced physicians...
The AngioJet device has been shown to be a safe and effective device for mechanical thrombectomy, yet its association with severe bradyarrhythmia has impeded its broad acceptance and widespread use. This “brady effect” has forced physicians...
The AngioJet device has been...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
David Antoniucci, MD
How to Minimize the Need for Temporary Pacemaker during Rheolytic Thrombectomy ABSTRACT: Background. Whatever the mechanism or mechanisms involved in the genesis of bradyarrhythmias during rheolytic thrombectomy (RT), the severity and...
How to Minimize the Need for Temporary Pacemaker during Rheolytic Thrombectomy ABSTRACT: Background. Whatever the mechanism or mechanisms involved in the genesis of bradyarrhythmias during rheolytic thrombectomy (RT), the severity and...
How to Minimize the Need for...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
David L. Coven, MD, PhD; Jacqueline Tamis-Holland, MD; Tariqshah Syed, MD; Mun K. Hong, MD
In Patients at High Risk for Symptomatic Bradycardia Undergoing AngioJet Mechanical Thrombectomy? ABSTRACT: We studied the feasibility and efficacy of glycopyrrolate, a synthetic anticholinergic agent with shorter half-life and without...
In Patients at High Risk for Symptomatic Bradycardia Undergoing AngioJet Mechanical Thrombectomy? ABSTRACT: We studied the feasibility and efficacy of glycopyrrolate, a synthetic anticholinergic agent with shorter half-life and without...
In Patients at High Risk for...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Bilal Murad, MD
ABSTRACT: Thrombectomy with the AngioJet® rheolytic thrombectomy catheter frequently causes bradyarrhythmias. This necessitates temporary pacemaker insertion and limits the device’s use. Novel approaches for treatment of bradyarrhythmias are...
ABSTRACT: Thrombectomy with the AngioJet® rheolytic thrombectomy catheter frequently causes bradyarrhythmias. This necessitates temporary pacemaker insertion and limits the device’s use. Novel approaches for treatment of bradyarrhythmias are...
ABSTRACT: Thrombectomy with the...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Augustin DeLago, MD, FACC, FSCAI; Mohammad El-Hajjar, MD; Mikhail Kirnus, MD
ABSTRACT: In patients with acute ST elevation myocardial infarction or in those with thrombus-containing lesions, percutaneous coronary intervention (PCI) represents a clinical challenge to the interventionist, because coronary thrombus is a...
ABSTRACT: In patients with acute ST elevation myocardial infarction or in those with thrombus-containing lesions, percutaneous coronary intervention (PCI) represents a clinical challenge to the interventionist, because coronary thrombus is a...
ABSTRACT: In patients with acute...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Gregory J. Dehmer, MD; Timothy A. Mixon, MD; Raul A. Santos, MD; D. Scott Gantt, DO; Mark E. Lawrence, DO; Linley E. Watson, MD
Induced by Rheolytic Thrombectomy and Precludes the Need for Transvenous Pacing: The Scott & White Experience ABSTRACT: Rheolytic thrombectomy (RT) is useful in certain percutaneous coronary interventions but may be associated with transient...
Induced by Rheolytic Thrombectomy and Precludes the Need for Transvenous Pacing: The Scott & White Experience ABSTRACT: Rheolytic thrombectomy (RT) is useful in certain percutaneous coronary interventions but may be associated with transient...
Induced by Rheolytic...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Dennis W.X. Zhu, MD
ABSTRACT: The AngioJet® Rheolytic™ Thrombectomy System (Possis Medical, Inc., Minneapolis, Minnesota) is an effective thrombectomy device, but it may cause bradycardias ranging from mild bradycardia to asystole and hypotension in some...
ABSTRACT: The AngioJet® Rheolytic™ Thrombectomy System (Possis Medical, Inc., Minneapolis, Minnesota) is an effective thrombectomy device, but it may cause bradycardias ranging from mild bradycardia to asystole and hypotension in some...
ABSTRACT: The AngioJet®...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Jeffrey J. Popma, MD, FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for revascularizing infarct-related arteries in patients experiencing acute myocardial infarction (AMI). Thrombolytic occlusion of the coronary artery is the inciting...
Primary percutaneous coronary intervention (PCI) is the preferred treatment for revascularizing infarct-related arteries in patients experiencing acute myocardial infarction (AMI). Thrombolytic occlusion of the coronary artery is the inciting...
Primary percutaneous coronary...
11/24/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Asad Sawar, MD; Shailendra Upadhyay, MD
Author Affiliations: From the Long Island Jewish Medical Center/Schneider Children’s Hospital, New Hyde Park, New York, and the *Bradenton Heart Center, Bradenton, Florida. The authors report no conflicts of interest regarding the content...
Author Affiliations: From the Long Island Jewish Medical Center/Schneider Children’s Hospital, New Hyde Park, New York, and the *Bradenton Heart Center, Bradenton, Florida. The authors report no conflicts of interest regarding the content...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Yuji Oikawa, MD; Junji Yajima, MD; Yoshitaka Shiratori, MD
Author Affiliations: From the Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 8, 2007, provisional acceptance...
Author Affiliations: From the Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 8, 2007, provisional acceptance...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Ruth H. Strasser, MD; O. Altmann, MD; Steffen P. Schoen, MD
Author Affiliations: From the Department of Cardiology, Heart Centre, University of Dresden, Germany. The authors report no conflicts of interest regarding the content herein. Manuscript submitted December 7, 2007, provisional acceptance...
Author Affiliations: From the Department of Cardiology, Heart Centre, University of Dresden, Germany. The authors report no conflicts of interest regarding the content herein. Manuscript submitted December 7, 2007, provisional acceptance...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Vidya Narayan, MD; Poonam Puri, MD; Anilkumar O. Mehra, MD
Author Affiliations: From the *Division of Cardiology, LAC and USC Medical Center, and the §ICCU, Department of Internal Medicine, Keck School of Medicine, Los Angeles, California. The authors report no conflicts of interest regarding the...
Author Affiliations: From the *Division of Cardiology, LAC and USC Medical Center, and the §ICCU, Department of Internal Medicine, Keck School of Medicine, Los Angeles, California. The authors report no conflicts of interest regarding the...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Andrew J.P. Klein, MD, FACC, FSCAI; Ivan P. Casserly, MD, MBBCh; John C. Messenger, MD, FACC, FSCAI
Author Affiliations: From the *University of Colorado at Denver Health Sciences, Division of Cardiology, and the §Denver VA Medical Center, Division of Cardiology, Denver, Colorado. The authors report no conflicts of interest regarding the...
Author Affiliations: From the *University of Colorado at Denver Health Sciences, Division of Cardiology, and the §Denver VA Medical Center, Division of Cardiology, Denver, Colorado. The authors report no conflicts of interest regarding the...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
William Keeble, BMedSci, BM, BS, MRCP, DM; Wayne J. Tymchak, MD, FRCP
A Case Report and Review of Pathophysiology Author Affiliations: From Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada. The authors report no conflicts of interest regarding the content herein. Manuscript submitted January...
A Case Report and Review of Pathophysiology Author Affiliations: From Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada. The authors report no conflicts of interest regarding the content herein. Manuscript submitted January...
A Case Report and Review of...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Selcuk Gormez, MD; Vedat Aytekin, MD; Refik Erdim, MD
Author Affiliations: From the Cardiology Department, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey. The authors report no conflicts of interest regarding the content herein. Manuscript submitted January 8, 2008,...
Author Affiliations: From the Cardiology Department, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey. The authors report no conflicts of interest regarding the content herein. Manuscript submitted January 8, 2008,...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Liza De Olazo Banaag, MD, CWS, FACCWS; Marissa J. Carter, PhD
Author Affiliations: From the Center for Wound Care & Hyperbaric Medicine at Grenada Lake Medical Center, Grenada, Mississippi. The author reports no conflicts of interest regarding the content herein. Manuscript submitted December 7,...
Author Affiliations: From the Center for Wound Care & Hyperbaric Medicine at Grenada Lake Medical Center, Grenada, Mississippi. The author reports no conflicts of interest regarding the content herein. Manuscript submitted December 7,...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Letters to the Editor
09/10/2008
Dear Editor,The recent article by Yoshimachi et al, entitled A Novel Method of PercuSurge Distal Protection in a Five French Guiding Catheter without an Export Aspiration Catheter1 is interesting as well as important, and deserves some...
Dear Editor,The recent article by Yoshimachi et al, entitled A Novel Method of PercuSurge Distal Protection in a Five French Guiding Catheter without an Export Aspiration Catheter1 is interesting as well as important, and deserves some...
Dear Editor,The recent article...
09/10/2008
Journal of Invasive Cardiology
Case Report
09/10/2008
Feng Zhang, MD; Junbo Ge, MD; Juying Qian, MD
ABSTRACT: Drug-eluting stents (DES) have been demonstrated to dramatically reduce the rate of in-stent restenosis (ISR). However, some studies found an increased rate of late incomplete stent apposition (ISA) and late stent thrombosis (ST) in...
ABSTRACT: Drug-eluting stents (DES) have been demonstrated to dramatically reduce the rate of in-stent restenosis (ISR). However, some studies found an increased rate of late incomplete stent apposition (ISA) and late stent thrombosis (ST) in...
ABSTRACT: Drug-eluting stents...
09/10/2008
Journal of Invasive Cardiology
Original Contribution
09/10/2008
Angel Sánchez-Recalde, MD, PhD; Raúl Moreno-Gómez, MD, PhD; Laura Barreales, MD; Fernando Rivero, MD; Guillermo Galeote, MD, PhD; Santiago Jimenez-Valero, MD, PhD; Luis Calvo-Orbe, MD; Esteban Lopez de Sa, MD; Jose Luis Lopez-Sendon, MD, PhD
A Meta-Analysis from 12 Randomized Trials ABSTRACT: Background. Incomplete stent apposition (ISA) is an unusual finding of intravascular ultrasound (IVUS) that may occur both after drug-eluting stent (DES) or bare-metal stent (BMS)...
A Meta-Analysis from 12 Randomized Trials ABSTRACT: Background. Incomplete stent apposition (ISA) is an unusual finding of intravascular ultrasound (IVUS) that may occur both after drug-eluting stent (DES) or bare-metal stent (BMS)...
A Meta-Analysis from 12...
09/10/2008
Journal of Invasive Cardiology
Original Contribution
09/10/2008
J. Eduardo Sousa, MD, PhD; Junya Ako, MD, PhD; Ichizo Tsujino, MD, PhD; Ali H.M. Hassan, MD; Yoshihisa Shimada, MD, PhD; Yasuhiro Honda, MD; Peter J. Fitzgerald, MD, PhD; Alexandre Antonio Cunha Abizaid, MD, PhD; Seung-Ho Hur, MD, PhD; Giulio Guagliumi, MD; Avinoam Shiran, MD; Sidney A. Cohen, MD, PhD; Basil S. Lewis, MD
ABSTRACT: Background. Diabetes has been reported as an independent predictor of restenosis after drug-eluting stent implantation. The purpose of this study was to assess the long-term impact of increased drug dose in sirolimus-eluting stents...
ABSTRACT: Background. Diabetes has been reported as an independent predictor of restenosis after drug-eluting stent implantation. The purpose of this study was to assess the long-term impact of increased drug dose in sirolimus-eluting stents...
ABSTRACT: Background. Diabetes...
09/10/2008
Journal of Invasive Cardiology
Original Contribution
09/10/2008
Amanda G.R.M. Sousa, MD, PhD; Jose de Ribamar Costa, Jr., MD, PhD; Ricardo A. Costa, MD, PhD; Galo Maldonado, MD; J. Eduardo Sousa, MD, PhD; Enilton T. Egito, MD; Edson R. Romano, MD; Marcos Barbosa, MD; Ricardo Pavanello, MD; César Jardim, MD; Abrão Cury, MD; Otávio Berwanger, MD, PhD; Manuel Cano, MD, PhD; Adriana Costa Moreira, MD, PhD
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite...
09/10/2008
Journal of Invasive Cardiology
Commentary
09/10/2008
Robert S. Dieter, MD, RVT; Pranab Das, MD; Aravinda Nanjundappa, MD, RVT, MBA
Adequate stent deployment is one of the most important technical factors during percutaneous coronary intervention. Inadequate stent expansion or apposition allows a nidus for stent thrombosis and in-stent restenosis. The factors affecting...
Adequate stent deployment is one of the most important technical factors during percutaneous coronary intervention. Inadequate stent expansion or apposition allows a nidus for stent thrombosis and in-stent restenosis. The factors affecting...
Adequate stent deployment is one...
09/10/2008
Journal of Invasive Cardiology
Original Contribution
09/09/2008
Jonathan M. Tobis, MD; Daniel L. Jurewitz, MD; Antonio Pessegueiro, MD; Raymond Zimmer, MD; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI
ABSTRACT: Background. Drug-eluting stents (DES) represent a significant improvement in the treatment of coronary artery disease as they decrease restenosis rates by approximately 50% compared with bare metal stents. In-stent restenosis (ISR)...
ABSTRACT: Background. Drug-eluting stents (DES) represent a significant improvement in the treatment of coronary artery disease as they decrease restenosis rates by approximately 50% compared with bare metal stents. In-stent restenosis (ISR)...
ABSTRACT: Background....
09/09/2008
Journal of Invasive Cardiology
Original Contribution
09/09/2008
Marcelo Santos de Freitas, MD; Carlos A.M. Gottschall, MD, PhD, FSCAI, FIAGS; Ibsen Suetonio Trindade, MD, PhD; Rogério Sarmento-Leite, MD, PhD
ABSTRACT: Objective. Determine minimum inflation time necessary for total stent expansion and apposition. Background. Complete stent expansion is needed to adequately support the increase in artery lumen and to accommodate neointimal growth....
ABSTRACT: Objective. Determine minimum inflation time necessary for total stent expansion and apposition. Background. Complete stent expansion is needed to adequately support the increase in artery lumen and to accommodate neointimal growth....
ABSTRACT: Objective. Determine...
09/09/2008
Journal of Invasive Cardiology
Original Contribution
09/08/2008
Plamen Gatzov, MD, PhD; Vassilis Voudris, MD; John Skoularikis, MD; Gentcho Gentchev, PhD; Athanassios Manginas, MD; Dennis V. Cokkinos, MD
Study in Patients with Single-Vessel Coronary Artery Disease  ABSTRACT: Objectives. To assess the effect of intravenous sodium nitroprusside and nitroglycerin on coronary blood flow distal to a severe coronary artery stenosis. Methods....
Study in Patients with Single-Vessel Coronary Artery Disease  ABSTRACT: Objectives. To assess the effect of intravenous sodium nitroprusside and nitroglycerin on coronary blood flow distal to a severe coronary artery stenosis. Methods....
Study in Patients with...
09/08/2008
Journal of Invasive Cardiology
Original Contribution
09/08/2008
Raphael A. Perry, MD, FRCP, BMBS, BSc; Sudhir Rathore, MD, MRCP; Anthony D. Grayson, BSc; Sanjay Sastry, MD; Timothy P. Gray, MD; Rhys Beynon, MD; Mark Jackson, PhD
ABSTRACT: Aim. To better describe the epidemiological causes of in-hospital death after percutaneous coronary intervention (PCI) in the present stent era. Methods. Systematic review of all in-hospital deaths following PCI in North West...
ABSTRACT: Aim. To better describe the epidemiological causes of in-hospital death after percutaneous coronary intervention (PCI) in the present stent era. Methods. Systematic review of all in-hospital deaths following PCI in North West...
ABSTRACT: Aim. To better...
09/08/2008
Journal of Invasive Cardiology